STADA Acquires Walmark from MidEuropa
November 4, 2019
STADA Arzneimittel AG has agreed to acquire Walmark a.s., a leading consumer healthcare company in Central Europe, from private equity firm MidEuropa Partners. The deal (consideration undisclosed) expands STADA's branded consumer health portfolio and strengthens its presence across Central and Eastern Europe; the transaction was expected to close in Q1 2020 subject to antitrust clearance.
- Buyers
- STADA Arzneimittel AG
- Targets
- Walmark a.s.
- Sellers
- MidEuropa Partners
- Industry
- Consumer Products
- Location
- Czech Republic
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
STADA Acquires Biopharma's Pharmaceutical Prescription and Consumer Health Business
December 12, 2019
Pharmaceuticals
The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.
-
MidEuropa Acquires Majority Stake in Optegra Eye Health Care
February 22, 2023
Healthcare Services
MidEuropa has completed the acquisition of a majority stake in Optegra Eye Health Care from H2 Equity Partners, with H2 and Optegra management reinvesting alongside MidEuropa. Optegra is a multi‑national ophthalmology platform operating 29 specialist facilities across the UK, Poland, Czech Republic and Slovakia and performs over 100,000 surgical procedures per year; MidEuropa intends to accelerate the company’s geographic expansion and growth across Europe.
-
Equistone Partners Europe Acquires Majority Stake in Omnicare
August 14, 2019
Pharmaceuticals
Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.
-
Astorg Acquires Majority Stake in Steliau
February 26, 2024
Industrial Services
Astorg, a European private equity firm, has signed an agreement to acquire a majority stake in Steliau, a pan-European value-added distributor (VAD) of electronic solutions, from B&Capital. Steliau, founded in 1992 and headquartered in Montrouge, France, employs more than 200 people across eight countries and will partner with Astorg to accelerate organic growth and execute a buy-and-build strategy.
-
STOK Acquires BEWI's Packaging Trading Business (BEWI Food)
October 30, 2024
Packaging
STOK, a portfolio company of A&M Capital Europe (AMCE), has entered into a binding agreement to acquire BEWI's trading business ("BEWI Food"), a leading distributor of food packaging in Norway and Iceland. The deal is STOK's first add-on since AMCE's April 2024 investment and is intended to create a leading packaging distributor across Denmark, Norway, Iceland and Greenland, with combined pro forma sales of ~€190m in 2024.
-
MidEuropa Acquires Controlling Stake in FAMAR
October 17, 2024
Pharmaceuticals
MidEuropa has acquired a controlling stake in FAMAR, a European contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners, with current shareholders and management reinvesting alongside MidEuropa. FAMAR employs around 1,900 people across six manufacturing sites and two R&D centres in southern Europe and will use MidEuropa's backing to support further growth and capability expansion in pharmaceutical manufacturing and R&D.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.